- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01672268
Interest of Cardiac Computed Tomography to Optimize and Improve the Procedure of TAVI (CT-TAVI)
November 24, 2014 updated by: University Hospital, Grenoble
Interest of Cardiac Computed Tomography (CT) to Optimize and Improve the Procedure of Transcatheter Aortic Valve Implantation (TAVI)
This is a pilot prospective, comparative, monocentric, randomized study with 2 groups.
People with a severe aortic stenosis and a high risk of surgery are referred to a Trans catheter aortic valve implantation (TAVI).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The proposed study is to show the interest of a cardiac computed tomography (CT) to improve the TAVI procedure.
The Cardiac computed tomography (CT) shows the exact geometry of the aortic annulus and help the physician to find the right position of the prosthesis during the procedure.
The hypothesis is that performing a cardiac CT before the TAVI could reduce the number of vascular peripheral complication, the number of stroke and can minimize the aortic regurgitation during the follow up.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Grenoble, France, 38700
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient with a symptomatic severe aortic stenosis with a too high risk of surgical valvular replacement. This patient will be selected for a TAVI. In this study, we only randomized patient for a TAVI with an Edwards prosthesis
- male or female patient, older than eighteen years old
- who have given their written consent
- who are affiliated to the French social security system
- which has a too high risk of surgical valvular replacement (EuroSCORE logistic > 20% or Society of Thoracic Surgeons Score > 10, or contre indicated to a cardiac surgery by a heart team
- Severe Aortic stenosis with symptoms like dyspnea, heartache, syncope, heart failure
Exclusion Criteria:
- Patient who can't give his written consent because of his physical or mental status
- Adult patient protect by law (article L1121-8),
- Person deprived of liberty (article L1121-8),
- Pregnant women
- Patient in terminal phase of illness,
- Terminal kidney failure
- Allergy to iodine
- bicuspids ou unicuspid aortic,
- Diameter of the left ventricular outflow tract < 18mm or > 25mm,
- Diameter of the femoral artery < 7mm, tortuosity or calcifications
- Septal hypertrophy
- Apical thrombosis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard TAVI procedure
Patients without Cardiac CT measures before TAVI
|
cardiac computed tomography, Transcatheter Aortic Valve Implantation, safety and efficacy
Other Names:
|
|
Experimental: Cardiac CT scan before TAVI procedure
patients with cardiac CT measures before TAVI
|
cardiac computed tomography, Transcatheter Aortic Valve Implantation, safety and efficacy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite end point
Time Frame: participants will be followed for the duration of 1 year
|
Composite end point with Stroke (symptoms and CT or MRI), Vascular complications (hematoma with the need of transfusion, dissection of artery/ legs ischemia), and Aortic regurgitation after the procedure, evaluated by transthoracic echocardiography
|
participants will be followed for the duration of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To compare results of transthoracic / transoesophageal echocardiography and cardiac CT
Time Frame: inclusion visit
|
• Size of the aortic annulus/ diameter and area
|
inclusion visit
|
|
To compare results of transthoracic / transoesophageal echocardiography and cardiac CT
Time Frame: inclusion visit
|
• Left ventricular outflow tract, anatomy of the aortic roots
|
inclusion visit
|
|
To compare results of transthoracic / transoesophageal echocardiography and cardiac CT
Time Frame: inclusion visit
|
• Left ventricular function, size, volume
|
inclusion visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gilles MD BARONE ROCHETTE, University Hospital, Grenoble
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
November 1, 2012
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
April 18, 2012
First Submitted That Met QC Criteria
August 21, 2012
First Posted (Estimate)
August 24, 2012
Study Record Updates
Last Update Posted (Estimate)
November 25, 2014
Last Update Submitted That Met QC Criteria
November 24, 2014
Last Verified
April 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-A001113-38 (Other Identifier: 2011-A001113-38)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Stenosis
-
National Institute of Cardiology, Warsaw, PolandThe Institute of Bioorganic Chemistry, Polish Academy of SciencesRecruitingAortic Stenosis | Low-gradient Aortic StenosisPoland
-
MiRusRecruitingAortic Stenosis | Symptomatic Severe Native Aortic StenosisUnited States
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
Edwards LifesciencesCompletedAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Azienda Ospedaliera "Sant'Andrea"University of Bologna; Politecnico di Milano; Centro Cardiologico Monzino; I.R.C...RecruitingAortic Stenosis | Calcific Aortic Valve Disease | Chronic Coronary Syndrome | Calcific Aortic StenosisItaly
-
Hospices Civils de LyonCompleted
-
Edwards LifesciencesRecruitingAortic Valve Stenosis | Aortic Stenosis, CalcificUnited States, Australia, Switzerland, Canada, Japan, Netherlands
-
Abbott Medical DevicesCompletedSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
University of AlbertaNot yet recruitingAortic Stenosis | Severe Aortic StenosisCanada
-
Medtronic CardiovascularCompleted
Clinical Trials on cardiac computed tomography
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingIschemic Stroke | Left Atrial Appendage Thrombosis | Cardioembolic Stroke | Thrombus; Embolism | Left Atrial ThrombosisNetherlands
-
Finn GustafssonCompleted
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
Triemli HospitalCompletedCoronary Artery Disease | Graft Failure | Bypass Complication
-
Marwan Sayed MahmoudUnknownParavalvular Leakage After TAVI
-
University of Turin, ItalyUniversity of Messina; Istituto Auxologico Italiano; Ministry of Health, Italy; A.O.U. Città della Salute e della Scienza - Molinette HospitalRecruiting
-
Universitätsklinikum Hamburg-EppendorfSiemens Healthcare Diagnostics IncNot yet recruitingCoronary Artery Disease | Acute Ischemic Stroke
-
Universitair Ziekenhuis BrusselCompleted
-
Queen Mary University of LondonActive, not recruitingContrast-induced Nephropathy | Ischaemic Heart DiseaseUnited Kingdom
-
Queen Mary University of LondonNational Institute for Health Research, United KingdomNot yet recruitingCoronary Heart Disease